Market Place
Sourcing Support
All News #Library
Biotech
AN2 Starts Ph2 Trial Epetraborole in M. Abscessus Lung Disease
31 Mar 2026 //
BUSSINESSWIRE
AN2 Therapeutics To Progress Oral Epetraborole Into Phase 2
03 Mar 2026 //
BUSINESSWIRE
AN2 Therapeutics Joins Chat at Leerink Healthcare Conference
17 Feb 2026 //
BUSINESSWIRE
AN2 Therapeutics To Launch 90-Patient Trial For Epetraborole
12 Jan 2026 //
BUSINESSWIRE
GSK & AN2 Partner on Boron-Based LeuRS Inhibitors for TB
10 Nov 2025 //
BUSINESS WIRE
AN2 Therapeutics Joins Fireside Chat At Evercore HealthCONx
06 Nov 2025 //
BUSINESS WIRE
AN2 Therapeutics, DNDi Develop Oral Compound for Chagas Disease
23 Jul 2025 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.